Search & Analyze
Popular Searches
Ajanta Pharma Ltd.
Healthcare₹3,369.202.31%
24 Jul, 4:01 PM
CMP₹3,369.20
Mkt Cap₹42.99K Cr
P/E40.71
P/B9.50
ROE25.42%
52W High₹3,598.40
52W Low₹2,335.00
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
40.71
P/B Ratio
9.50
EV/EBITDA
27.50
Price/Sales
7.88
Dividend Yield (%)
0.81
EPS (TTM ₹)
84.52
Book Value (₹)
362.09
ROE (%)
25.42
ROCE (%)
32.67
ROA (%)
18.59
EBITDA Margin (%)
12.35
Net Profit Margin (%)
9.35
Debt/Equity
0.05
Current Ratio
2.38
Interest Coverage
86.52
Asset Turnover
1.99
Working Capital/Sales
4.87
Core EBITDA Growth (%)
15.72
P&L
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 3340.99 | 3742.64 | 4208.71 | 4648.1 | 5452.86 |
| Net Sales | 3340.99 | 3742.64 | 4208.71 | 4648.1 | 5452.86 |
| Total Income | 3456.67 | 3841.28 | 4293.31 | 4742.6 | 5624.93 |
| Total Expenditure | 2411.7 | 2959.39 | 3036.77 | 3388.6 | 4058.03 |
| Operating Profit | 1044.97 | 881.89 | 1256.54 | 1354 | 1566.9 |
| Depreciation | 125.29 | 130.8 | 135.4 | 144.11 | 173.14 |
| Exceptional Items | — | — | — | — | — |
| Profit Before Tax | 909.48 | 745.25 | 1113.93 | 1189.16 | 1377.65 |
| Tax | 196.8 | 157.27 | 297.76 | 268.77 | 321.65 |
| Profit After Tax (PAT) | 712.68 | 587.98 | 816.17 | 920.39 | 1056 |
| EPS (₹) | 54.97 | 45.89 | 64.82 | 73.56 | 84.53 |
| Dividend Payout % | 475 | 350 | 2550 | 1400 | 1400 |
Balance Sheet
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 17.17 | 25.27 | 25.27 | 25.07 | 25.07 |
| Reserves | 3246.87 | 3362.38 | 3536.44 | 3760.04 | 4498.8 |
| Shareholders Funds | 3264.34 | 3387.99 | 3567.36 | 3790.29 | 4527.09 |
| Total Debt | 1.9100000000000001 | 1.43 | 1.49 | 2.59 | 211.99 |
| Total Liabilities | 4196.75 | 4704.65 | 4503.94 | 4828.52 | 6246.57 |
| Total Assets | 4196.75 | 4704.65 | 4503.94 | 4828.52 | 6246.57 |
| Book Value / Share | 382.1956 | 269.0675 | 282.8928 | 303.044 | 362.1922 |
| Assets | 4196.75 | 4704.65 | 4503.94 | 4828.52 | 6246.57 |
Cash Flows
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 561.71 | 792.11 | 785.07 | 1157.23 | 529.19 |
| Investing Activities | -74.1 | -559.6 | 65.39 | -376.52 | -428.92 |
| Financing Activities | -459.71 | -108.2 | -1051.06 | -733.41 | -167.92 |
| Net Cash Flow | 27.9 | 124.31 | -200.6 | 47.3 | -67.65 |
AJANTPHARM
₹3,369.20
-2.31%